Amgen acquiring Micromet for $11 per share in cash, or about $1.2B

Micromet Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Amgen Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed